e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
Novel treatments for cough, asthma, COPD and bronchiectasis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Nociceptin modulates the inflammatory immune microenvironment in a conventional murine model of asthma
Giuseppe Spaziano (Naples, Italy), Giuseppe Spaziano, Maria Matteis, Rosalinda Sorrentino, Fiorentina Roviezzo, Giuseppe Cirino, Aldo Pinto, Francesco Rossi, Gioia Tartaglione, Manuela Sgambato, Bruno D’Agostino
Source:
International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Session:
Novel treatments for cough, asthma, COPD and bronchiectasis
Session type:
Thematic Poster Session
Number:
3951
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Giuseppe Spaziano (Naples, Italy), Giuseppe Spaziano, Maria Matteis, Rosalinda Sorrentino, Fiorentina Roviezzo, Giuseppe Cirino, Aldo Pinto, Francesco Rossi, Gioia Tartaglione, Manuela Sgambato, Bruno D’Agostino. Nociceptin modulates the inflammatory immune microenvironment in a conventional murine model of asthma. Eur Respir J 2015; 46: Suppl. 59, 3951
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Activation of the β-catenin pathway by Wnt-1 treatment suppress inflammation in the mouse model of allergic airway disease
Source: International Congress 2015 – Advances in asthma and allergy in animal models
Year: 2015
The role of IL-17 producing NK cells and other innate immune cells in poly(I:C) triggered exacerbation of experimental asthma
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016
Activin-A is a critical inducer of human CD4+ICOS+IL-10-secreting regulatory T cells that suppress allergen-driven T cell responses in vitro and experimental asthma in a humanized mouse model in vivo
Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions
Year: 2015
Increased influx of progenitor B cell subsets in the lung with diverse levels of
in-situ
proliferation and activation in a murine model of allergic inflammation
Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation
Year: 2014
Dysregulation of type 2 innate lymphoid cells and Th2 cells impairs pollutant-induced allergic airway responses
Source: International Congress 2016 – Immune responses in the lung
Year: 2016
Aquaporin-3 potentiates murine asthma through mediating T-cell trafficking and chemokine production
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016
Role of the T-cell homing receptor in the immune mechanisms of the allergic march
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016
IL-25 induces airways angiogenesis and expression of multiple angiogenic factors in a murine asthma model
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015
CD38 gene-modified dendritic cells inhibit murine asthma development through increasing IL-12 production and promoting Th1 cell differentiation
Source: International Congress 2016 – Immune responses in the lung
Year: 2016
Association between T-regulatory cells blood content and Th2 cells activity in asthma
Source: Annual Congress 2013 –Asthma: new mechanisms and markers
Year: 2013
IL-37 requires IL18Rα and SIGIRR to diminish experimental allergic airway inflammation in mice
Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions
Year: 2015
D-tryptophan influences allergic airway inflammation and Th2 immune responses
Source: International Congress 2015 – Asthma mechanisms and management
Year: 2015
Enhanced inflammatory gene expression in bronchial epithelial cells from asthmatic patients: Attenuation by a Brd4 mimic
Source: International Congress 2014 – Novel targets and drugs for asthma and COPD
Year: 2014
IL-25 receptor expression on basophil membrane is related to phenotype and severity of asthma
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015
TLR 7/8 agonist resiquimod alleviates murine allergic asthma through IL-27 production and up regulation of B7-H1 on antigen presenting cells
Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions
Year: 2015
B cells in a murine model of allergic asthma and respiratory tolerance
Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions
Year: 2015
Effect of mast cells degranulation blockade on the inflammatory response outcome in the COPD model
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
Imbalance of pro-inflammatory and anti-inflammatory markers on circulating dendritic cells in COPD
Source: International Congress 2014 – TH17 and other acute asthmatic responses
Year: 2014
TLR-3 triggered exacerbation of experimental asthma depends on IL-17 producing NK cells
Source: International Congress 2014 – TH17 and other acute asthmatic responses
Year: 2014
An antedrug of the CXCL12 neutraligand blocks experimental allergic asthma without systemic effect in the mouse
Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept